Long-term Extension Study for Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies
Janssen Research & Development, LLC
Summary
The purpose of this study is to assess the long-term safety and tolerability after an intravitreal injection (a shot of medicine into the eye) of JNJ-81201887 administered in parent clinical studies.
Eligibility
- Age range
- 60+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Participants who were enrolled and received treatment with JNJ-81201887 or sham in a parent clinical study (81201887MDG2001, 81201887MDG1003) * Females (women of childbearing potential), male participants, and partners of male participants will not be required to use contraception in this LTE study * Must sign an informed consent form (ICF) indicating that participant understands the purpose of, and procedures required for, the study and is willing to participate in the study. The ICF may be signed by an impartial witness and/or legally designated representative dependin…
Interventions
- DrugJNJ-81201887
No study intervention will be administered as part of this LTE study.
- OtherSham Procedure
No study intervention will be administered as part of this LTE study.
Locations (104)
- Retina Associates Southwest PCTucson, Arizona
- Retina Consultants of Orange CountyFullerton, California
- Shiley Eye Institute Jacobs Retina CenterLa Jolla, California
- California Retina ConsultantsOxnard, California
- California Eye Medical SpecialistsPasadena, California
- Retina Consultants San DiegoPoway, California